Related Experiment Video
Updated: Jul 14, 2026
10:58
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
Current management strategies for ovarian cancer
Giovanni D Aletti1, Mary M Gallenberg, William A Cliby
1Division of Gynecologic Surgery, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Mayo Clinic Proceedings
|June 7, 2007
Summary
Epithelial ovarian cancer, a deadly gynecologic malignancy, requires advanced screening and treatment. This review highlights recent surgical and systemic therapy improvements for ovarian cancer management.
Area of Science:
- Gynecologic Oncology
- Molecular Oncology
Background:
- Epithelial ovarian cancer (EOC) is a significant cause of cancer mortality in women, often diagnosed at advanced stages.
- The disease readily metastasizes within the peritoneal cavity and lymphatic system, frequently preceding symptom onset.
- High mortality rates underscore the urgent need for improved screening and therapeutic strategies for ovarian cancer.
Purpose of the Study:
- To provide an overview of epithelial ovarian cancer.
- To emphasize recent advancements in the operative management of ovarian cancer.
- To highlight recent progress in systemic therapies for ovarian cancer.
Main Methods:
- Review of current literature on ovarian cancer management.
- Analysis of recent technological advances in understanding ovarian cancer biology.
- Synthesis of information on surgical cytoreduction and chemotherapy.
Main Results:
- Epithelial ovarian cancer spreads rapidly, leading to late-stage diagnoses and high mortality.
- While chemotherapy improves survival rates, complete disease eradication remains a challenge.
- Molecular insights have identified novel therapeutic targets in ovarian cancer cells.
Conclusions:
- Optimal treatment involves cytoreductive surgery followed by chemotherapy.
- Advances in understanding molecular targets offer new therapeutic avenues for ovarian cancer.
- Continued research into screening and treatment is crucial for improving patient outcomes in ovarian cancer.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...